Neurocrine Biosciences to Particpate at the UBS Virtual CNS Day 2024 Conference
Eiry Roberts, Chief Medical Officer, and Kyle Gano, Chief Business Development and Strategy Officer, will present at the UBS Virtual CNS Day Conference at 12:00 p.m. Eastern Time on Monday March 18, 2024.
OPEN WEBCAST
Neurocrine Biosciences to Particpate at the Stifel 2024 Virtual CNS Days Conference
Kyle Gano, Chief Business Development and Strategy Officer, and Grace Liang, Vice President of Clinical Development, will present at the Stifel 2024 Virtual CNS Days Conference at 2:00 p.m. Eastern Time on Tuesday March 19, 2024.
OPEN WEBCAST
Neurocrine Biosciences to Participate at the Barclays 26th Annual Global Healthcare Conference on March 13 in Miami
Kyle Gano, Chief Business Development and Strategy Officer, and Todd Tushla, Vice President of Investor Relations, will present at the Barclays 26th Annual Global Healthcare Conference at 10:15 a.m. Eastern Time on Wednesday March 13, 2024 in Miami.
OPEN WEBCAST
Neurocrine Biosciences to Participate at the Leerink Partners Global Biopharma Conference on March 12 in Miami
Matt Abernethy, Chief Financial Officer, and Kyle Gano, Chief Business Development and Strategy Officer, will present at the Leerink Partners Global Biopharma Conference at 8:40 a.m. Eastern Time on Tuesday March 12, 2024 in Miami.
OPEN WEBCAST
Neurocrine Biosciences to Participate at the TD Cowen 44th Annual Healthcare Conference on March 5 in Boston
Matt Abernethy, Chief Financial Officer, and Kyle Gano, Chief Business Development and Strategy Officer, will present at the TD Cowen 44th Annual Healthcare Conference at 11:10 a.m. Eastern Time on Tuesday March 5, 2024 in Boston.